ThoRAciC Trauma IntubatiON Risk Score for Blunt Trauma — TRACTIONS  

Trauma Chest Clinical Trial

Official title: ThoRAciC Trauma IntubatiON Risk Score for Blunt Trauma

Status Recruiting

Clinical Trial Summary

The primary objective of this study is the evaluation of risk factors associated with orotracheal intubation in blunt chest trauma patients not intubated on the field and not fulfilling the criteria for intubation based on the Glasgow Coma scale score with the building of a predictive score based on those findings taking into account the clinical, laboratory and radiologic tests performed within 6 hours from hospital admission.

Clinical Trial Description

Multicentre, prospective, observational study. All the consecutive blunt thoracic trauma patients consecutively admitted at the participating institutions' Emergency Department (ED) will be considered for enrolment. The primary outcome measure will be the need for orotracheal intubation for primary respiratory failure lasting at least 48 hours within 7 days after trauma. The secondary outcome measures related to analgesia are: the basal analgesia protocol received during the first 7 days from ED admission and the median cumulative dose of morphine-equivalents received as rescue therapy during the first 7 days after trauma. The secondary outcome measure related to the sonographic evolution of thoracic lesions is the global and regional LUS. ;

Related Conditions & MeSH terms

• Trauma Chest
• Wounds and Injuries

• NCT number: NCT05637944
• Study type: Observational [Patient Registry]
• Source: Azienda Usl di Bologna
• Contact: Lorenzo Gamberini, MD
• Phone: 0039 051 6478215
• Email: lorenzo.gamberini@ausl.bologna.it
• Status: Recruiting
• Start date: October 1, 2022
• Completion date: October 1, 2024